4-(3,4-dichlorophenoxy)-2,5-difluoro-N-(methylsulfonyl)benzamide

ID: ALA4537339

PubChem CID: 117760464

Max Phase: Preclinical

Molecular Formula: C14H9Cl2F2NO4S

Molecular Weight: 396.20

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CS(=O)(=O)NC(=O)c1cc(F)c(Oc2ccc(Cl)c(Cl)c2)cc1F

Standard InChI:  InChI=1S/C14H9Cl2F2NO4S/c1-24(21,22)19-14(20)8-5-12(18)13(6-11(8)17)23-7-2-3-9(15)10(16)4-7/h2-6H,1H3,(H,19,20)

Standard InChI Key:  KASGDBJYKOICKB-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 24 25  0  0  0  0  0  0  0  0999 V2000
    3.6526   -1.7045    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.4450   -1.9192    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    4.2347   -1.1256    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.0403   -4.3748    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0392   -5.1944    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7472   -5.6033    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4569   -5.1939    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4541   -4.3712    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7455   -3.9660    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7470   -6.4205    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.0392   -6.8289    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3351   -6.4171    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6277   -6.8249    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6271   -7.6429    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3397   -8.0515    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0441   -7.6414    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3312   -5.6024    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    5.1602   -3.9600    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    2.3424   -8.8687    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.9198   -8.0523    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    3.7430   -3.1488    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4495   -2.7381    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.0341   -2.7423    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.1536   -1.5102    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  2  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9  4  1  0
  6 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 11  1  0
  5 17  1  0
  8 18  1  0
 15 19  1  0
 14 20  1  0
  9 21  1  0
 21 22  1  0
 21 23  2  0
 22  2  1  0
  2 24  1  0
M  END

Associated Targets(Human)

SCN9A Tclin Sodium channel protein type IX alpha subunit (8393 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SCN5A Tclin Sodium channel protein type V alpha subunit (3462 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KCNH2 Tclin HERG (29587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 396.20Molecular Weight (Monoisotopic): 394.9597AlogP: 3.75#Rotatable Bonds: 4
Polar Surface Area: 72.47Molecular Species: ACIDHBA: 4HBD: 1
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 4.00CX Basic pKa: CX LogP: 3.30CX LogD: 2.36
Aromatic Rings: 2Heavy Atoms: 24QED Weighted: 0.85Np Likeness Score: -1.48

References

1. DiMauro EF, Altmann S, Berry LM, Bregman H, Chakka N, Chu-Moyer M, Bojic EF, Foti RS, Fremeau R, Gao H, Gunaydin H, Guzman-Perez A, Hall BE, Huang H, Jarosh M, Kornecook T, Lee J, Ligutti J, Liu D, Moyer BD, Ortuno D, Rose PE, Schenkel LB, Taborn K, Wang J, Wang Y, Yu V, Weiss MM..  (2016)  Application of a Parallel Synthetic Strategy in the Discovery of Biaryl Acyl Sulfonamides as Efficient and Selective NaV1.7 Inhibitors.,  59  (17): [PMID:27441383] [10.1021/acs.jmedchem.6b00425]

Source